Drugmaker Novo Nordisk reaches market value of $500 million

[ad_1] Demand for obesity drugs has pushed Novo Nordisk’s share price to new highs. ADVERTISEMENT The rush on weight loss drugs has sent Danish drugmaker Novo Nordisk’s market value to…

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

[ad_1] A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021. Brian Snyder | Reuters AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for…

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie…

Drugmaker Novo Nordisk seeks obesity, diabetes ‘bolt-on’ deals

[ad_1] Flags with the Novo Nordisk logo flutter outside their Danish company’s offices in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little Acquire Licensing Rights Novo first to market with effective…

French drugmaker Sanofi considers listing consumer unit late next year

[ad_1] The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights Oct 27 (Reuters) –…

Swiss drugmaker Novartis to help make Pfizer-BioNTech COVID-19 vaccine

[ad_1] The logo of Swiss drugmaker Novartis is pictured at the French company’s headquarters in Rueil-Malmaison near Paris, France, April 22, 2020. REUTERS/Charles Platiau/File Photo Acquire Licensing Rights ZURICH, Jan…

Drugmaker helping Elon Musk worth more than Denmark

[ad_1] Manufactured by Danish pharma company Novo Nordisk, Wegovy is the only weight-loss drug approved by the FDA. Steffen Trumpf—picture alliance/Getty Images A global surge in demand for weight-loss treatments…

Italy’s Alfasigma to buy drugmaker Intercept for nearly $800 mln

[ad_1] Sept 26 (Reuters) – Italy’s Alfasigma S.p.A said on Tuesday it had agreed to buy U.S. drugmaker Intercept Pharmaceuticals ICPT.O for $794 million to expand its presence in the…

Bankrupt drugmaker Mallinckrodt considers sale of opioid business – WSJ

[ad_1] Bottles of prescription painkillers Oxycodone Hydrochloride, 30mg pills, made by Mallinckrodt sit on a counter at a local pharmacy, in Provo, Utah, U.S., April 25, 2017. REUTERS/George Frey/File Photo…

WSJ News Exclusive | Bankrupt Drugmaker Mallinckrodt Considers Sale of Opioid Business

[ad_1] Bankrupt Drugmaker Mallinckrodt Considers Sale of Opioid …  The Wall Street Journal [ad_2] Source link